← Leaderboards
Edward A Levine
Wake Forest University Health Sciences
$1,866,520
Attributed
$1,866,520
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $222.5K · FY2005–21$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,866,520 · 9
By mechanism
P30$1,525,039 · 3
R21$255,370 · 1
M01$86,111 · 5
Top collaborators
No co-investigators on record.
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Edward G Shaw$22,365,759
- Nancy E Avis$9,658,718
- Isabelle M Berquin$1,923,047
- Ralph B. Dagostino$15,515,654
- Abbott J Garvin$0
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelOnline SystemsDatabasesNormal Tissue MorphologyTissuesTumor TissueResearch Project GrantsNeoplasticQuality ControlRepositoryLaboratoriesSpecimenTissue ProcessingTissue SampleHuman TissueTissue BanksMemberProspectiveSamplingCollectionForestHuman ResourcesFundingServices
Grant awards (29)
Tumor Tissue and Pathology Shared Resource$99,457
P30 · FY2021 · CA · contact PI
Tumor Tissue and Pathology Shared Resource$98,890
P30 · FY2020 · CA · contact PI
Tumor Tissue and Pathology Shared Resource$157,647
P30 · FY2019 · CA · contact PI
Tumor Tissue and Pathology Shared Resource$29,410
P30 · FY2019 · CA · contact PI
Tumor Tissue and Pathology Shared Resource$14,689
P30 · FY2019 · CA · contact PI
Tumor Tissue and Pathology Shared Resource$11,763
P30 · FY2019 · CA · contact PI
Tumor Tissue and Pathology Shared Resource$5,639
P30 · FY2019 · CA · contact PI
Tumor Tissue and Pathology Shared Resource$3,397
P30 · FY2019 · CA · contact PI
Tumor Tissue Core$147,410
P30 · FY2016 · CA · contact PI
Tumor Tissue Core$98,455
P30 · FY2015 · CA · contact PI
Tumor Tissue Core$98,455
P30 · FY2014 · CA · contact PI
Tumor Tissue Core$82,065
P30 · FY2013 · CA · contact PI
Tumor Tissue Core$3,123
P30 · FY2013 · CA · contact PI
Tumor Tissue Core$2,603
P30 · FY2013 · CA · contact PI
Tumor Tissue Core$87,767
P30 · FY2012 · CA · contact PI
Tumor Tissue Core$117,593
P30 · FY2011 · CA · contact PI
Tumor Tissue Core$135,683
P30 · FY2010 · CA · contact PI
CLINICAL TRIAL: STUDY OF TAMOXIFEN AND RALOXIFENE (STAR) FOR PREVENTION OF BREAS$3,462
M01 · FY2010 · RR · contact PI
Tumor Tissue Core$142,999
P30 · FY2009 · CA · contact PI
CLINICAL TRIAL: STUDY OF TAMOXIFEN AND RALOXIFENE (STAR) FOR PREVENTION OF BREAS$5,840
M01 · FY2009 · RR · contact PI
Tumor Tissue Core$126,085
P30 · FY2008 · CA · contact PI
CLINICAL TRIAL: STUDY OF TAMOXIFEN AND RALOXIFENE (STAR) FOR PREVENTION OF BREAS$13,420
M01 · FY2008 · RR · contact PI
Tumor Tissue Core$61,909
P30 · FY2007 · CA · contact PI
STUDY OF TAMOXIFEN AND RALOXIFENE (STAR) FOR PREVENTION OF BREAST CANCER$16,779
M01 · FY2007 · RR · contact PI
STUDY OF TAMOXIFEN AND RALOXIFENE (STAR) FOR PREVENTION OF BREAST CANCER$18,202
M01 · FY2006 · RR · contact PI
STUDY OF TAMOXIFEN AND RALOXIFENE (STAR) FOR PREVENTION OF BREAST CANCER$18,192
M01 · FY2005 · RR
Study of Tamoxifen and Raloxifene (STAR) for Prevention of Breast Cancer$10,216
M01 · FY2004 · RR
PET IN MULTIMODALITY THERAPY FOR ESOPHAGEAL CANCER$128,094
R21 · FY2002 · CA
PET IN MULTIMODALITY THERAPY FOR ESOPHAGEAL CANCER$127,276
R21 · FY2001 · CA